Colony Group LLC Abbott Laboratories Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Colony Group LLC holds 190,537 shares of ABT stock, worth $24.4 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

190,537

Previous 159,804 19.23%

Holding current value

$24.4 Million

Previous $17.4 Million 5.92%

% of portfolio

0.28%

Previous 0.25%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $2.94 Million - $3.52 Million	30,733 Added 19.23%	190,537 $18.5 Million
Q2 2023 Aug 15, 2023	SELL	$100.78 - $112.29 $144,115 - $160,574	-1,430 Reduced 0.89%	159,804 $17.4 Million
Q1 2023 May 16, 2023	SELL	$96.86 - $114.01 $1.58 Million - $1.86 Million	-16,313 Reduced 9.19%	161,234 $16.3 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.04 Million - $1.22 Million	10,902 Added 6.54%	177,547 $19.5 Million
Q3 2022 Nov 15, 2022	BUY	$96.76 - $112.03 $238,513 - $276,153	2,465 Added 1.5%	166,645 $16.1 Million
Q2 2022 Aug 16, 2022	BUY	$102.07 - $123.37 $2.18 Million - $2.64 Million	21,402 Added 14.99%	164,180 $17.8 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $13 Million - $15.9 Million	114,150 Added 398.74%	142,778 $16.9 Million
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $20,910 - $25,604	181 Added 0.64%	28,628 $4.03 Million
Q3 2021 Nov 17, 2021	SELL	$116.66 - $129.06 $355,229 - $392,987	-3,045 Reduced 9.67%	28,447 $3.36 Million
Q2 2021 Aug 18, 2021	SELL	$105.79 - $124.53 $564,812 - $664,865	-5,339 Reduced 14.5%	31,492 $3.65 Million
Q1 2021 May 21, 2021	BUY	$108.84 - $128.23 $642,591 - $757,069	5,904 Added 19.09%	36,831 $4.41 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $41,580 - $45,310	-396 Reduced 1.26%	30,927 $3.39 Million
Q3 2020 Nov 17, 2020	BUY	$91.64 - $111.29 $54,250 - $65,883	592 Added 1.93%	31,323 $3.41 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $150,613 - $192,766	1,967 Added 6.84%	30,731 $2.81 Million
Q1 2020 May 18, 2020	SELL	$62.82 - $91.86 $842,353 - $1.23 Million	-13,409 Reduced 31.8%	28,764 $2.27 Million
Q4 2019 Feb 18, 2020	BUY	$78.51 - $87.4 $548,156 - $610,226	6,982 Added 19.84%	42,173 $3.66 Million
Q3 2019 Nov 26, 2019	SELL	$81.84 - $88.74 $70,382 - $76,316	-860 Reduced 2.39%	35,191 $2.94 Million
Q2 2019 Aug 19, 2019	BUY	$72.88 - $85.0 $697,607 - $813,620	9,572 Added 36.15%	36,051 $3.03 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $4.59 Million - $5.55 Million	-69,325 Reduced 72.36%	26,479 $2.12 Million
Q4 2018 Feb 15, 2019	SELL	$65.56 - $74.27 $9,965 - $11,289	-152 Reduced 0.16%	95,804 $6.93 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $63,059 - $76,074	-1,037 Reduced 1.07%	95,956 $7.04 Million
Q2 2018 Aug 15, 2018	SELL	$57.57 - $63.54 $1.81 Million - $2 Million	-31,474 Reduced 24.5%	96,993 $5.92 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $6.64 Million - $7.51 Million	118,089 Added 1137.88%	128,467 $7.7 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $557,091 - $596,423	10,378	10,378 $592,000

Others Institutions Holding ABT

# of Institutions

3,244

Shares Held

1.31B

Call Options Held

8.71M

Put Options Held

8.03M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $225B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account